Pro: Should Aspirin Be Continued After Cardiac Surgery in the Setting of Thrombocytopenia?

ASPIRIN is one of the most cost-effective therapies available for the prevention and treatment of platelet-mediated vascular occlusive disorders, which consist of a heterogenous group of disorders including myocardial infarction (MI), stroke, and vascular graft thrombosis. In a meta-analysis of 195 randomized clinical trials that included more than 140,000 patients at high risk, patients given aspirin demonstrated a 22% reduction (10.7% v 13.2%;...